Anti-inflammatory response in patients with obstructive jaundice caused by biliary malignancy

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 4, 2001, Pages 467-472

  Kimura, Fumio ^a   Miyazaki, Masaru ^b   Suwa, Toshikazu ^a   Sugiura, Toshiyuki ^a   Shinoda, Tokuzou ^a   Itoh, Hiroshi ^b   Nagakawa, Koji ^b   Ambiru, Satoshi ^b   Shimizu, Hiroaki ^b   Yoshitome, Hiroyuki ^b  

^a SAITAMA RED CROSS HOSPITAL   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Anti inflammatory response; Biliary malignancy; Interleukin 1 receptor antagonist; Interleukin 10; Interleukin 6; Obstructive jaundice; Postoperative complications; Soluble CD14; Soluble tumor necrosis factor receptor p55; Soluble tumor necrosis factor receptor p75

Indexed keywords

CD14 ANTIGEN; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; BILIARY TRACT DRAINAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; JAUNDICE; MALE; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL;

EID: 0035030331     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02465.x     Document Type: Article

References (35)

1. Research into the results of resection of hilar bile duct cancer
2. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice
3. Plasma cytokine levels and monocyte activation in patients with obstructive jaundice
4. Multiple organ damage caused by tumor necrosis factor and prevented by prior neutrophil depletion
5. Monoclonal antibody to tumor necrosis factor a attenuates cardiopulmonary dysfunction in porcine gram-negative sepsis
6. A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits
7. Effect of antitumor necrosis factor treatment on circulating tumor necrosis factor levels and mortality after surgery in jaundiced mice
8. Hyperactive cytokine response after partial hepatectomy in patients with biliary obstruction
9. Interleukin-6 in the injured patients
10. Anti-inflammatory cytokine profile and mortality in febrile patients
11. High levels of interleukin-10 in serum are associated with fatality in meningococcal disease
12. Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations
13. Plasma concentration of cytokine antagonists in patients with infection following liver resection
14. CD14: A receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
15. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage
16. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock
17. Serum levels of CD14 in neonatal sepsis by Gram-positive and Gram-negative bacteria
18. Conclusive evidence of endotoxaemia in biliary obstruction
19. IL-10 inhibits cytokine production by activated macrophages
20. Characterization of interleukin-10 receptors on human and mouse cells
21. Radical oncologic surgery affects the circulatory levels of interleukin 10
22. Increased concentrations of tumor necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality
23. Persistent systemic inflammatory response after stent insertion in patients with malignant bile duct obstruction
24. Shedding of tumor necrosis factor receptors by activated human neutrophils
25. IL-1 receptor antagonist and IL-1β production in human monocytes are regulated differently
26. The effect of differentiating agents on IL-1β production in cultured human monocytes
27. Hepatic protein synthesis and cytokines in obstructive jaundice
28. Endotoxin related early neutrophil activation is associated with outcome after thoracoabdominal aortic aneurythm repair
29. CD14 is a pattern recognition receptor
30. Soluble CD14(1-152) confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay
31. Interleukin-10 inhibits antimicrobial activity against Leishmania major in murine macrophages
32. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia
33. Stabilization of the bioactivity of tumour necrosis factor by its soluble receptors
34. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells
35. Preoperative external biliary drainage in obstructive jaundice; a prospective controlled trial